Description: This 1978 session focused on regulatory considerations in Group Health Insurance focused on the following questions: 1. What is the impact of National Health Insurance and Federal Hospital Cost Control? 2. What is the impact of non-discrimination legislation and regulation? 3. What is the impact of recent OASDI financing changes and changes in mandatory retirement age? 4. What is the future of multi-employer trusts and self-insurance?

Description: This panel will discuss the current status of NAIC activities with respect to risk-based capital RBC. The potential impact on financial reporting with respect to health products, specifically, indemnity, HMO, disability, and nontraditional products will also be discussed. From the Record of the Society of Actuaries, Vol.21, No. 4a.

Description: This 1978 panel discussed risk classification systems for a variety of products. Topics covered included: 1. regulatory and social policy encroachment on risk classification systems 2. possible changes in underwriting/marketing strategy because of changed regulatory requirements 3. use of the social imperative via regulation or legislation to mandate availability of coverage to high risk classifications 4. implied use of the risk classification system to provide incentives to control socially undesirable behavior 5. potential use of private mass coverage to minimize the impact on risk classification systems for coverages mandated by law or social policy 6. the ultimate in risk classification systems: self-insurance

Description: This 1980 session is about effect of government actions and consumerism on product design and pricing. Areas addressed: 1. What have been the most important regulatory and consumerist actions in the past decade as related to products, their marketing and the overall operation of a life insurance company? 2. What will be the most important actions in these arenas in the next decade? 3. What specific impact have these regulatory and consumer actions had on companies in the past decade and will they have in the coming decade? 4. What true value has accrued to consumers and the public because of these actions, and what impact will they have in the next decade? 5. Is there an acceptable relationship between the value of these benefits and the cost to the companies of providing them?

Description: This session from the 1994 Valuation Actuary Symposium covers long term care and health related issues for valuation, an update from the Risk-Based Capital Task Force of the Academy on developing a risk-based capital formula for health coverages, an overview of the health practice notes.

Description: On Dec. 29, 1973 President Nixon signed into law the Health Maintenance Organization Act of 1973, which authorizes $375 million to be used by the DHEW to stimulate the establishment and development of HMO's over the next five years. This article describes the status of the regulations and the development of additional HMO's.

Description: This session from the 1992 Valuation Actuary Symposium reviews the appointed actuary concept, the actuarial opinion and asset adequacy analysis as they apply to health insurance and expresses the views of one regulator on the subject and one actuary in terms of the actuarial standards of practice.

Description: 1993 SOA Spring Meeting, San Diego. In this session the panelists provided five different perspectives of small-group health insurance reform. Perspectives included: 1. Legislative issues perspective. 2. A small group insurance company perspective. 3. The employer perspective. 4. The reinsurance perspective. 5. The compliance perspective.

Description: This paper explores the legislation of New York 65, the intent of which was to offer health benefits to persons age 65 and over without health examination or other evidence of insurability. From TRANSACTIONS OF SOCIETY OF ACTUARIES, 1962 VOL. 14, PT. 1 NO. 40.

Description: This session from the 1984 SOA Salt Lake City Meeting discusses health insurance including the topics of the Washington loss ratio report, problems which lead to regulatory difficulties later on, claims monitoring, setting claim reserves and pricing individual health policies.